Rima Kulkarni

Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice.

Rima Kulkarni, Zhuanfang Wang, R M Wang et al. · Journal of Clinical Investigation · 1997 · 298 citations · Full text

Life Sciences, Endocrinology, Physiology +17

The HIV-1 Reverse Transcriptase M184I Mutation Enhances the E138K-Associated Resistance to Rilpivirine and Decreases Viral Fitness

Rima Kulkarni, Kerim Babaoglu, E.B. Lansdon et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 86 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide

Nicolas Margot, Pamela Wong, Rima Kulkarni et al. · The Journal of Infectious Diseases · 2017 · 38 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Characterization of HIV-1 Drug Resistance Development Through Week 48 in Antiretroviral Naive Subjects on Rilpivirine/Emtricitabine/Tenofovir DF or Efavirenz/Emtricitabine/Tenofovir DF in the STaR Study (GS-US-264-0110)

Danielle Porter, Rima Kulkarni, Todd Fralich et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2013 · 27 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study^*

Danielle Porter, Jonathan Toma, Yuping Tan et al. · HIV Clinical Trials · 2016 · 26 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17